Research & Development



  在周慶的注視下,梁甲的手不斷地在寶劍跟錢袋上方晃悠,他很難衡量這兩個東西那個更加值錢一些。   “汝為何知曉茶葉之妙?”日本免费av无码片网站   那里的紈褲子弟真的可以橫行無忌不用顧忌後果嗎?kk4444在线观看   八千名騎兵在荒原上呼喝奔馳,驅趕野獸,中間還夾雜著披著紅色斗篷的羽林。   “難道說君為主上分憂還要挑揀一番不成?”经典AV三级在线   太宰喟嘆一聲道︰“我何嘗不知道反漢復秦只是徒然撈月,無奈祖宗遺囑如此,我們身為後輩只能繼續下去。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo